Skip to content
RollCall logo

Podcasts

Coronavirus Special Report: What’s next for the surplus of hydroxychloroquine?

Bottles of hydroxychloroquine pills wait to be distributed in hospitals in San Salvador, El Salvador, on April 21.
Bottles of hydroxychloroquine pills wait to be distributed in hospitals in San Salvador, El Salvador, on April 21. (Yuri Cortez/AFP via Getty Images file photo)
By Jason Dick and Evan Campbell
Posted May 7, 2020 at 6:24pm

In tonight’s podcast, we delve into the latest in health policy news: What will states that purchased the malaria drug hydroxychloroquine do with their supplies of the increasingly discredited COVID-19 treatment option? And what should we expect from Dr. Anthony Fauci’s Senate testimony next week? Also, Republican lawmakers reckon with oversight.

Recent Stories

Sen. Kevin Cramer, R-N.D., wants the debt limit addressed by congressional Republicans this fall while they are still in the majority.

Cramer calls for debt limit action in lame-duck session

At the Races: Family in the fray

Rep. Greg Murphy, R-N.C., speaks with diners at Mae’s Restaurant in Seven Springs, N.C., before sunrise on Oct. 16.

Capitol Lens — Carolina campaigning

From left, Sens. Mike Lee, R-Utah., Shelley Moore Capito, R-W.Va., Martin Heinrich, D-N.M., and Sheldon Whitehouse, D-R.I., hold a news conference on the permitting bill in the Capitol on Sept. 30, 2026. (Bill Clark/CQ Roll Call)

Permitting bill writers seek industry aid ahead of Senate vote

Sen. Darline Graham is facing a tighter than expected race in South Carolina. Above, she speaks to supporters at a Charleston County get out the vote event on Oct. 17.

Why Republicans are ‘nervous’ over South Carolina 

The Office of the Comptroller of the Currency headquarters in Washington. (Kevin Carter/Getty Images)

Stablecoin yield rule revives crypto vs. banking industry fight